317 related articles for article (PubMed ID: 25452296)
1. Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome.
Jones C; Levy Y; Tong AW
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25452296
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
Thurmes PJ; Steensma DP
Eur J Haematol; 2006 Jul; 77(1):57-60. PubMed ID: 16827884
[TBL] [Abstract][Full Text] [Related]
3. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
[TBL] [Abstract][Full Text] [Related]
4. The role of serum erythropoietin level and JAK2 V617F allele burden in the diagnosis of polycythaemia vera.
Ancochea A; Alvarez-Larrán A; Morales-Indiano C; García-Pallarols F; Martínez-Avilés L; Angona A; Senín A; Bellosillo B; Besses C
Br J Haematol; 2014 Nov; 167(3):411-7. PubMed ID: 25040297
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
[TBL] [Abstract][Full Text] [Related]
6. Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Tutaeva V; Misurin AV; Michiels JJ; Rozenberg JM; Sokolova MA; Ivanova VL; Kolosheinova TI; Manakova TE; Levina AA; Semenova EA; Khoroshko ND
Hematology; 2007 Dec; 12(6):473-9. PubMed ID: 17852451
[TBL] [Abstract][Full Text] [Related]
7. Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.
Coskun ME; Height S; Dhawan A; Hadzic N
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710306
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
[TBL] [Abstract][Full Text] [Related]
9. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
10. The role of a low erythropoietin level for the polycythemia vera diagnosis.
Lupak O; Han X; Xie P; Mahmood S; Mohammed H; Donthireddy V
Blood Cells Mol Dis; 2020 Feb; 80():102355. PubMed ID: 31525610
[TBL] [Abstract][Full Text] [Related]
11. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
Johansson P; Safai-Kutti S; Lindstedt G; Suurküla M; Kutti J
Acta Haematol; 2002; 108(1):1-7. PubMed ID: 12145459
[TBL] [Abstract][Full Text] [Related]
12. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
13. The utility of testing erythropoietin level in polycythemia diagnosis.
Ismail A; Abdalla E; Aqel A; Fadul A; Ahmed A; Alsayed A; Musa M; Yassin MA
Hematology; 2023 Dec; 28(1):2269510. PubMed ID: 37843428
[TBL] [Abstract][Full Text] [Related]
14. [Unclear liver fibrosis in a 42-year-old patient with polycythemia vera].
Gundling F; Kreth F; Tröltzsch M; Tannapfel A; Bödeker H; Mössner J
Internist (Berl); 2004 Nov; 45(11):1293-8. PubMed ID: 15372168
[TBL] [Abstract][Full Text] [Related]
15. Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.
Birgegård G; Wide L
Br J Haematol; 1992 Aug; 81(4):603-6. PubMed ID: 1390249
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia and the Budd-Chiari syndrome: study of serum erythropoietin and bone marrow erythroid progenitors.
Levy VG; Ruskone A; Baillou C; Theirman-Duffaud D; Najman A; Boffa GA
Hepatology; 1985; 5(5):858-61. PubMed ID: 4029896
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.
Hirshberg B; Shouval D; Fibach E; Friedman G; Ben-Yehuda D
J Hepatol; 2000 Apr; 32(4):574-8. PubMed ID: 10782905
[TBL] [Abstract][Full Text] [Related]
18. How to manage polycythemia vera.
Passamonti F
Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736
[TBL] [Abstract][Full Text] [Related]
19. [Budd-Chiari syndrome and Vaquez disease: apropos of a case. Results of medical and surgical treatment of Budd-Chiari syndrome].
Szappanyos-Vuaridel D; Rudolf H; Wichser J; Loizeau E
Schweiz Med Wochenschr; 1986 Nov; 116(47):1648-51. PubMed ID: 3541173
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias.
Najean Y; Schlageter MH; Toubert ME; Podgorniak MP
Nouv Rev Fr Hematol (1978); 1990; 32(4):237-40. PubMed ID: 2290709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]